Skip to main content
Equibles

STIFEL FINANCIAL CORP

Position in XFOR — X4 Pharmaceuticals, Inc

CIK 720672 ST. LOUIS, MO
Back to XFOR Full portfolio

Position in XFOR

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$86,483
-$3,505 QoQ
Shares Held
18,519
-15.0% QoQ
Ownership
0.019%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#59
of 89 holders
Holding Since
Mar 2022
16 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in XFOR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

STIFEL FINANCIAL CORP holds $538,947,950 across 105 Biotechnology names. XFOR ranks #97 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 BHVN
Biohaven Ltd.
 9,941,165 $147,924,534
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 162,151 $80,545,262
3 MANE
Veradermics, Inc
 294,117 $36,158,743
4 JAZZ
Jazz Pharmaceuticals plc
 139,491 $33,613,146
5 REGN
Regeneron Pharmaceuticals, Inc.
 46,378 $28,918,535
6 OMER
Omeros Corp
 1,836,925 $17,469,155
7 NTLA
Intellia Therapeutics, Inc.
 1,014,387 $17,163,427
8 IONS
Ionis Pharmaceuticals Inc
 202,983 $16,094,521

All Filings in XFOR

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $86,483 18,519
2026-03-31 $89,988 21,789
2025-12-31 $81,984 20,496
2025-03-31 $17,829 75,550
2024-12-31 $55,494 75,607
2024-09-30 $81,917 122,448
2024-06-30 $95,274 164,267
2024-03-31 $119,852 86,225
2023-12-31 $75,889 90,452
2023-09-30 $87,503 80,278
2023-06-30 $157,751 81,315
2023-03-31 $81,342 93,497
2022-12-31 $81,422 81,996
2022-09-30 $115,122 67,323
2022-06-30 $65,121 67,483
2022-03-31 $121,798 69,599